Search Results
Found 5 results
510(k) Data Aggregation
(191 days)
CARDIAC PATHWAYS CORP.
The Cardiac Pathways Tracking System catheters are indicated for cardiac electrophysiological mapping and delivering diagnostic pacing stimuli. In addition, the Tracking catheters are used with the Arrhythmia Mapping and Tracking System to provide catheter location information.
The Cardiac Pathways Tracking diagnostic catheters are indicated for cardiac electrophysiological mapping and delivering pacing stimuli. In addition, the Tracking and Reference Catheters are used with the Arrhythmia Mapping and Tracking System to provide catheter location information.
The Cardiac Pathways Arrhythmia Mapping and Tracking System allows the recording, viewing, and analysis of intracardiac electrograms and EKG signals to aid in the diagnosis and localization of cardiac arrhythmias. The System also allows the recording, viewing, and annotation of diagnostic electrophysiology (EP) catheter positions and electrode positions. The system facilitates the simultaneous recording of signals through connections to standard EP mapping catheters, specialized EP mapping catheters, and a 12-lead EKG.
The Cardiac Pathway Arrhythmia Mapping and Tracking System is intended for use in applications of diagnostic EP mapping and consists of the following:
- a signal recording computer system for interpreting mapping signals and documenting . locations of catheters and catheter electrodes,
- . electrogram signal amplifier electronics,
- ultrasound transmit and receive electronics,
- . a set of diagnostic electrophysiology reference catheters containing ultrasound ranging transducers and mapping electrodes (referred to as Reference Catheters, RV Reference Catheters, and CS Reference Catheters),
- one or more diagnostic electrophysiology tracking catheters containing ultrasound ranging transducers and mapping electrodes (referred to as Tracking Catheters, Steerable Catheters, and Radii Catheters with Tracking),
- . cabling to connect transducers and electrodes to recording equipment, and
- . software for interfacing the electronics and displaying catheter locations to the operator.
Here's an analysis of the provided text, focusing on acceptance criteria and study details:
1. Table of Acceptance Criteria and Reported Device Performance
The provided text does not explicitly state formal acceptance criteria with numerical targets. Instead, it describes general verification and validation activities. However, based on the performance data section, we can infer some criteria and the reported performance.
| Acceptance Criteria (Inferred) | Reported Device Performance |
|---|---|
| Electrical Safety | Devices met specifications. |
| Electrical Parameters within Specification | Devices met specifications (ee.g., continuity, short circuits, DC impedance, AC impedance, capacitance, dielectric strength, current leakage). |
| Functional Performance | Devices met specifications. Software verification testing was performed and deemed acceptable for clinical use. |
| Transducer Accuracy | Accuracy of the transducers was tested. (No specific numerical value given for transducers, but implied to be within acceptable limits for overall accuracy) |
| Catheter Mechanical Properties (Joint strength, torque, deflection) | Devices met mechanical specifications. |
| Biocompatibility | Testing indicated devices did not elicit toxicological responses. |
| Tracking Function Accuracy (Key performance claim) | **In vitro and in vivo assessment showed tip location accuracy of |
Ask a specific question about this device
(90 days)
CARDIAC PATHWAYS CORP.
The Mercator Atrial High Density Array Catheter is intended to be used in the right atrium of patients with complex arrhythmias that may be difficult to identify using conventional mapping systems alone (i.e., linear mapping catheters). When used in conjunction with electrogram recording equipment and stimulators, the system is used to record intracardiac electrogram (EGM) signals and to deliver pacing pulses for the purpose of diagnostic provocative stimulation during an electrophysiology procedure.
The Mercator Atrial High Density Array Catheter can be used with:
- the Cardiac Pathways' Model 8100 Arrhythmia Mapping System and the Model 8300 . Signal Acquisition Module in conjunction with a stimulator, and
- Cardiac Pathways' EGM Adapter Cables (Models 2036, 2043, and 2044) in conjunction . with intracardiac electrogram recording equipment.
Prescription Use
(Per 21 CFR 801.109)
The Mercator High Density Array Catheter has an 8.5F catheter shaft with a collapsible, spheroid-shaped. 32-bipole-electrode array (64 electrodes) on the distal end, and an integrated cable/connector assembly on the proximal end. The device is designed to connect/mate directly with the Cardiac Pathways' Arrhythmia Mapping System and with Cardiac Pathways' EGM Adapter Cables. The EGM Adapter Cables can be connected to electrogram recording equipment.
The Mercator High Density Array Catheter has been described previously in the 510(k) Summary and the Device Description section in the 510(k) submission file number K982540.
There are three different EGM Adapter Cables for use with the Mercator Catheter. The distal end of the cable is identical in each of the three cable types and defined as the end that connects to the Mercator High Density Array Catheter. The proximal end connects to electrogram recording equipment.
The distal end of the EGM Adapter Cables is a threaded-body style connector that has contacts for each of the 64 electrodes of the Mercator High-Density Array Catheter and a contact for a shield wire. The proximal end of the cable distinguishes the three EGM Adapter Cables. The Model 2036 EGM Adapter Cable allows for general connection of individual electrodes to electrogram recorders and stimulators. This cable has 64 independent connectors on the proximal end. Model 2043 and Model 2044 EGM Adapter Cables have connector configurations that can mate with Prucka CardioLab recording systems. These cables have two connectors on the proximal end. On each of these two connectors, 33 contacts connect 32 electrodes and 1 shield wire from the Mercator High-Density Array Catheter to the inputs on the Prucka system. The two Prucka connector cable models differ in that one model has pin-type contacts and the other model has socket-type contacts to adapt to suitable models of the Prucka recording system. The EGM Adapter Cables are not sterilized since they are not in the sterile field during a procedure.
The provided text describes a 510(k) summary for the Mercator Atrial High Density Array Catheter and Cardiac Pathways EGM Adapter Cables. It focuses on device description, indications for use, and a statement of substantial equivalence to a predicate device (K982540). The document mentions that the Mercator catheter was subjected to bench, animal, and clinical testing, and the EGM Adapter Cables underwent electrical and mechanical tests.
However, the specific details required to answer your questions regarding acceptance criteria and the comprehensive study that proves the device meets them are not provided in the given text. The document states that the testing for the catheter has been "described previously in the 510(k) Summary for the 510(k) submission file number, K982540," and for the cables, it only states that "The device met the specifications" without listing those specifications or the details of the tests.
Therefore, I cannot extract the following information from the provided text:
- A table of acceptance criteria and the reported device performance: No specific acceptance criteria or performance metrics (e.g., sensitivity, specificity, accuracy) are reported for the catheter in this document. For the cables, it only states "met the specifications" for electrical and mechanical tests, but the specifications themselves are not detailed.
- Sample size used for the test set and the data provenance: No information on test set sample sizes or data provenance (country, retrospective/prospective) is present.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable as no specific test set or ground truth establishment details are provided.
- Adjudication method for the test set: Not applicable.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance: This device is a catheter and adapter cables, not an AI or imaging diagnostic tool. Therefore, an MRMC study with human readers assessing AI performance is not relevant to this product.
- If a standalone (i.e., algorithm only without human-in-the loop performance) was done: Not applicable, as this is a medical device, not an algorithm.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc.): No ground truth information is provided.
- The sample size for the training set: Not applicable, as this is a hardware device, not a machine learning algorithm.
- How the ground truth for the training set was established: Not applicable.
The document essentially refers to a prior 510(k) summary (K982540) for the performance data of the Mercator Catheter and provides only a very high-level summary for the EGM Adapter Cables. To answer your questions comprehensively, the original 510(k) summary (K982540) would need to be reviewed.
Ask a specific question about this device
(190 days)
CARDIAC PATHWAYS CORP.
The Mercator Atrial High-Density Array Catheter, used in conjunction with the Cardiac Pathways' Model 8100 Arrhythmia Mapping System and the Model 8300 Signal Acquisition Module, is intended to be used in the right atrium of patients with complex arrhythmias that may be difficult to identify using conventional mapping systems alone (i.e., linear mapping catheters). The system is used to record intracardiac electrogram (EGM) signals and to deliver pacing pulses for the purpose of diagnostic provocative stimulation during an electrophysiology procedure.
The Mercator High Density Array Catheter has an 8.5F catheter shaft with a collapsible, spheroidal-shaped, 32 bipole electrode array on the distal end, and an integrated cable/connector assembly on the proximal end. The device is designed to interface with the Cardiac Pathways' Arrhythmia Mapping System. There are three sizes of arrays for the right atrium based on the atrial volume derived from transthoracic echocardiograms: 70 cc, 100 cc, and 130 cc.
The electrode array consists of eight equidistant arms fixed at each end to form a spheroid. The arms terminate into an atraumatic tip on the distal end, and transition into the catheter shaft on the proximal end. The arms are made of a compliant material that maintains contact against the atrial walls during the cardiac cycle. The arms are labeled A through H in a clockwise direction. The array orientation is ascertained using three radiopaque markers positioned on arms A (distal), B (mid) and C (proximal). Each arm has four electrode pairs spaced equidistant from each other along the length of each arm. Each electrode is 0.75 mm wide by 0.25 mm high. The electrode spacing is the same for all three sizes of catheters: 1 mm between electrodes in a bipole and 8 mm between bipoles when measured center to center.
The electrical connections between the electrodes on the array and the connector on the proximal end of the catheter are made via cables. The cables run the length of the catheter shaft and connector bump tubing. The catheter shaft terminates at the proximal end at the Y-arm assembly. The center lumen of the catheter is contiguous with the luer fitting on the straight arm of the Y-arm assembly and is used for flushing the catheter. The angled arm on the Y-arm assembly provides the interface for the connector bump tubing.
The connector has 79 pins, and interfaces with a mating receptacle on the Arrhythmia Mapping System. The terminations of the cables at the connector are housed inside a backshell that provides a smooth transition from the connector to the connector burnp tubing.
The 11 F Guiding Sheath and the 30° Angled Guiding Sheath have an 11 F braided catheter shaft that terminates into a short, atraumatic tip on the distal end and a luer fitting on the proximal end. On the 30° Angled Guiding Sheath, the distal 4.5 cm of the catheter shaft is angled 30° from the proximal shaft of the catheter. The 11 F Guiding Sheath and the 30° Angled Guiding Sheath are used in conjunction with the 8.5 F Pigtail Catheter and the 30° Angled 8.5 F Pigtail Catheter, respectively, to position the High Density Array Catheter in the right atrium.
The 11 F Guiding Sheaths have a large inside diameter through which the High Density Array Catheter is inserted into and withdrawn from the cardiovascular system. The shaft of the Guiding Sheath is radiopaque. The Guiding Sheath terminates into a female luer fitting on the proximal end. This luer fitting is used to flush the Guiding Sheath and to introduce the High Density Array Catheter into the Guiding Sheath. The working length of the Guiding Sheath is 110 cm.
The purpose of the Guiding Sheath is to "guide" the High Density Array Catheter to a position in the right atrium found using the 8.5 F Pigtail Catheter. The Guiding Sheath is also used to collapse and withdraw the electrode array on the High Density Array Catheter when mapping is complete
The 8.5 F Pigtail Catheter and the 30° Angled 8.5 F Pigtail Catheter have an 8.5 F braided catheter shaft on the proximal end attached to a soft distal extrusion that is necked down and formed into a radius known as a " pigtail". The 8.5 F Pigtail Catheter and the 30° Angled 8.5 F Pigtail Catheter are used in conjunction with the 11 F Guiding Sheath to position the High Density Array Catheter in the right atrium.
The Pigtail Catheters have an open center lumen and 12 side holes positioned equidistant from each other in the distal extrusion, proximal to the pigtail. These holes can be used to deliver contrast media into the right atrium for visualization of catheter position and to assess the size of the atrium. The center lumen is accessible for flushing using a female luer lock fitting on the proximal end of the Pigtail Catheter. The braided shaft is radiopaque and gives the catheter good torque transmission.
The diameter of the pigtail tip is 1.3 cm. The purpose of this large diameter tip is to facilitate atraumatic placement into the right atrium. It also helps to avoid prolapsing of the High Density Array Catheter through the tricuspid valve into the right ventricle. The working length of the Pigtail Catheter is 135 cm.
A pigtail stylet is packaged in the Deployment Kit to straighten out the distal radius of the pigtail when inserting it inside the Guiding Sheath. The stylet is a stainless steel mandrel with a ball on the end to prevent advancing it all the way into the center lumen of the Pigtail Catheters. The pigtail stylet is used only in the preparation of the Guiding Sheath/Pigtail Catheter assembly and is not intended to be inserted into a patient. It is removed after the Pigtail Catheter is positioned inside the Guiding Sheath.
The Mercator Atrial High Density Array Catheter is intended to record intracardiac electrogram (EGM) signals and to deliver pacing pulses for diagnostic provocative stimulation during an electrophysiology procedure in the right atrium of patients with complex arrhythmias.
Here is an analysis of its acceptance criteria and the study proving its performance:
1. Acceptance Criteria and Reported Device Performance
The provided document does not explicitly list quantitative acceptance criteria for the device's performance. Instead, it focuses on demonstrating substantial equivalence to predicate devices. The performance data assesses diagnostic quality, signal quality, rhythm interpretations, and baseline noise compared to standard catheters. Since the device is intended to enable diagnosis, the ability to successfully record and interpret signals is paramount.
| Performance Metric | Acceptance Criteria (Implied by Equivalence Study) | Reported Device Performance |
|---|---|---|
| Diagnostic Quality (Sinus Rhythm) | Equivalent to standard diagnostic commercial catheters (p=1.000) | Overall diagnostic quality in sinus rhythm rated as "identical" between HDAC and standard catheters (p = 1.000). Recordings acceptable for diagnosis in all patients with both devices. Rhythm diagnosis was sinus rhythm in all cases with both devices. |
| Signal Quality (Sinus Rhythm) | Similar to standard diagnostic commercial catheters (p=0.8643) | Overall signal quality in sinus rhythm rated as "similar" between HDAC and standard catheters (p = 0.8643). |
| Diagnostic Quality (Atrial Arrhythmia) | Similar to standard diagnostic commercial catheters (p=0.1177 and Kappa = 0.799) | Overall diagnostic quality in atrial arrhythmia rated as "similar" between HDAC and standard catheters (p = 0.1177). Recordings acceptable for diagnosis in all patients with both devices. Arrhythmia diagnoses were similar with the two devices (Kappa = 0.799). |
| Signal Quality (Atrial Arrhythmia) | No difference from standard diagnostic commercial catheters (p=0.4559) | Overall signal quality in atrial arrhythmia showed "no difference" among catheters (p = 0.4559). |
| Baseline Noise | Equivalent to standard diagnostic commercial catheters (p=0.5450 for mean, p=0.8970 for patient mean) | Mean baseline noise per electrode pair: 0.019 ± 0.096 mV for HDAC vs. 0.016 ± 0.075 mV for standard catheters (p = 0.5450). Proportion of electrode pairs with baseline noise: 6.8% for HDAC vs. 7.6% for standard catheters. Mean baseline noise per patient was similar for both devices (p = 0.8970). Equivalence was demonstrated regardless of comparison method. |
| Pacing Capture Consistency | High consistency (no specific threshold given, but "consistent capture" is implied as positive performance feedback) | Consistent capture of one or more bipole pairs at 5 mA was achieved in 96.9% of patients. Pacing capture was also determined at 2 mA. |
| Safety Profile | Excellent safety profile compared to comparison groups, no major adverse events related to the device itself (e.g., thromboembolism, perforation, valve injury, thrombus on catheter) | No instances of thromboembolic events, cardiac perforation, or valve injury reported. No evidence of thrombus on 92 inspected HDAC catheters. One procedure-related major adverse event (left femoral hematoma) not directly attributed to the device design itself. Three minor, procedure-related adverse events occurred, also not directly attributed to the device design. |
2. Sample Size and Data Provenance
- Test Set Sample Size: 74 patients for data analysis in the clinical study. A total of 79 patients were enrolled, but 5 were excluded because the HDAC was not deployed.
- For matched electrogram analysis in sinus rhythm: 41 patients.
- For matched electrogram analysis in atrial arrhythmia: 45 patients.
- Data Provenance: Prospective clinical study conducted at eight centers. The country of origin is not explicitly stated, but given the FDA 510(k) submission, it is almost certainly a US-based study or a multinational study that includes US sites.
3. Number of Experts and Qualifications for Ground Truth
- Number of Experts: A "blinded independent expert" was used to perform the primary analyses of equivalence. Only one expert is explicitly mentioned for this comparative assessment.
- Qualifications of Experts: The specific qualifications (e.g., "Radiologist with 10 years of experience") are not detailed for the independent expert, only that they were an "expert." For an electrophysiology study, such an expert would typically be an electrophysiologist with significant experience in interpreting intracardiac electrograms.
4. Adjudication Method
The document states that the "primary analyses of equivalence... were performed by a blinded independent expert." This suggests a single expert's interpretation formed the basis of the comparison without an explicit multi-reader adjudication method (e.g., 2+1 or 3+1 consensus). However, the study also compared diagnoses to "predefined diagnostic categories," implying a structured framework for assessment.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No Multi-Reader Multi-Case (MRMC) comparative effectiveness study was explicitly mentioned to assess how much human readers improve with AI vs. without AI assistance. The study focuses on the standalone performance of the device and its equivalence to predicate devices, with human readers (the "independent expert") evaluating the quality of the signals from both the investigational and predicate devices. This device is a diagnostic catheter, not an AI assistance tool.
6. Standalone Performance Study (Algorithm-Only)
A standalone performance study was done in the sense that the device's ability to record and pace was evaluated on its own merits alongside the comparison to predicate devices. The study assessed:
- The device's ability to capture pacing (96.9% consistent capture at 5 mA).
- The intrinsic qualities of its recorded electrograms (diagnostic quality, signal quality, baseline noise) as interpreted by an expert, compared to standard catheters.
- The device's mechanical and electrical specifications compliance through laboratory testing. These are inherently "standalone" assessments of the device itself.
7. Type of Ground Truth Used
The ground truth for the clinical study was primarily established by:
- Expert Interpretation/Diagnosis: The "blinded independent expert" determined the diagnostic quality, rhythm diagnoses, and signal quality based on the electrogram recordings. This represents expert consensus on the interpretation of physiological signals.
- Patient Diagnosis/Medical History: The study population itself had verified arrhythmias (e.g., atrial flutter, AV nodal tachycardia), which served as the clinical context for evaluating the diagnostic performance of the catheters.
- Objective Measurements: For baseline noise, objective measurements (peak-to-peak absolute amplitude) were taken from the signals.
8. Sample Size for the Training Set
This document describes a clinical validation study and does not mention a "training set" in the context of an AI/machine learning algorithm, as the device itself is a physical medical instrument (catheter), not a software algorithm that requires a training set. The clinical study acts as the validation set for the device's performance against its intended use.
9. How the Ground Truth for the Training Set was Established
As mentioned above, there is no "training set" in the context of an AI/machine learning algorithm for this device. The physical device's design and engineering would have been guided by prior medical knowledge, engineering principles, and potentially animal or bench testing (which are not detailed here for ground truth establishment). The ground truth for the clinical validation was established through expert interpretation of electrograms and patient clinical diagnosis.
Ask a specific question about this device
(64 days)
CARDIAC PATHWAYS CORP.
The Radii Diagnostic Electrophysiology Catheter is intended to be used to record intracardiac electrogram (EGM) signals and to deliver pacing pulses for the purpose of diagnostic provocative stimulation during an electrophysiology procedure.
The Radii Diagnostic Electrophysiology Catheter is a 7 F steerable, deflectable, quadrapolar catheter. It has a 4 mm tip electrode and three 1 mm ring electrodes in the flexible distal tip and a handle at the proximal end. The catheter is available in several curve sizes, two shaft stiffnesses, and two electrode spacings. The four electrodes at the distal end of the catheter include one 4 mm electrode at the distal tip, and three 1 mm ring electrodes placed at specified distances proximal to the tip electrode. One interelectrode spacing configuration is 2 mm, 5 mm, and 2 mm (2,5,2) and the other interelectrode spacing configuration is 2 mm, 2 mm, and 2 mm (2,2,2). Each of the electrodes is attached to a conductor that extends from the electrode to a specific pin in the connector in the handle. The shaft has two lumens, one for the electrode wires and the other for the pull-wire. To facilitate the transmission of rotational force, the shaft includes braiding sandwiched between layers of tubing. At the proximal end of the handle (i.e., farthest from the shaft), there is a connector for connecting the device to an external stimulator and electrophysiologic recorder. The knob utilized to deflect the tip is on the distal end of the handle (i.e., nearest to the shaft). This knob is connected to the tip by the pull-wire. Pulling the knob toward the connector causes the tip to deflect, with the extent of deflection controlled by the extent of movement of the knob. Pushing the knob toward the shaft causes the tip to straighten. Rotating the handle to the right rotates the catheter tip counterclockwise or clockwise, respectively (as viewed from the handle). The Radii Catheter connects to an electrophysiologic recorder using an EGM Cable designed specifically for the connector configuration on the recorder. Each cable has a connector on one end that mates to the connector on the Radii Catheter and a connector on the other end that mates to the recorder. Within the insulated cable bundle, each conductor is insulated. A separate cable is utilized for connecting the Radii Catheter to an external stimulator. Like the EGM Cables, this cable has a connector on one end that mates to the connector on the Radii Catheter and a connector on the other end that mates to the stimulator. Each conductor within the insulated cable bundle is insulated. Because many pacing stimulators do not contain protected-pin attachments (these are designed into the Cardiac Pathways cable), a Pin Adaptor is provided with the cable to allow for a variety of connection situations.
The provided text describes a medical device, the Radii Diagnostic Electrophysiology Catheter, and its 510(k) summary for premarket notification. However, it does not contain a detailed study proving the device meets specific acceptance criteria in terms of performance metrics like sensitivity, specificity, accuracy, or any clinical outcomes.
Instead, the document focuses on demonstrating substantial equivalence to predicate devices through:
- Device Description: Detailing the physical characteristics, materials, and functionality.
- Intended Use/Indications: Clearly stating the purpose of the device.
- Performance Data (Engineering Bench Testing): Summarizing that the device underwent electrical, mechanical, and biocompatibility testing and "met the specifications." This is typical for demonstrating safety and basic functionality in a 510(k) for such a device, rather than a clinical performance study with detailed statistical results.
Therefore, many of the requested elements (sample size for test set, data provenance, number of experts for ground truth, MRMC study, standalone performance, training set details) are not applicable or not found in this document because the type of study described is a series of engineering and bench tests, not a clinical trial or performance evaluation employing those methodologies.
Here's a breakdown of what can be extracted from the provided text:
Acceptance Criteria and Reported Device Performance
| Acceptance Criteria | Reported Device Performance | Comments |
|---|---|---|
| Electrical Specifications (e.g., continuity, short circuits, DC/AC impedance, capacitance, dielectric strength, current leakage) | "The device met the specifications." | Specific quantitative values for "specifications" are not provided. |
| Mechanical Specifications (e.g., joint strengths, ability to withstand multiple deflections) | "The device met the specifications." | Specific quantitative values for "specifications" are not provided. |
| Biocompatibility | "Biocompatibility testing was performed to verify that the devices did not elicit toxicological responses." | Indicates compliance with biocompatibility standards, but specific test results or thresholds are not detailed. |
Study Details (Based on available information)
- Sample size used for the test set and the data provenance: Not explicitly detailed. The "test set" refers to physical units of the device and cables used for engineering bench testing, not a clinical data set. Data provenance is not applicable in the context of bench testing of physical devices.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. Ground truth for engineering tests is based on predefined technical specifications and measurements, not expert clinical consensus.
- Adjudication method for the test set: Not applicable. Engineering tests rely on objective pass/fail criteria against specifications.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done: No, an MRMC study was NOT done. This type of study is relevant for diagnostic imaging or interpretation where human readers' performance is evaluated. The Radii Catheter is a diagnostic device for recording signals and delivering pacing, not for interpretation of complex clinical data by humans that would require an MRMC study.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. The Radii Catheter is a physical medical device, not an algorithm, so standalone algorithm performance is not a concept that applies.
- The type of ground truth used: For the electrical and mechanical tests, the ground truth was the predetermined engineering specifications and standards set for the device's components and overall function. For biocompatibility, it was compliance with biocompatibility standards to ensure no toxicological responses.
- The sample size for the training set: Not applicable. This refers to the training of an algorithm, which is not relevant to this device.
- How the ground truth for the training set was established: Not applicable.
Summary from the provided text:
The 510(k) summary focuses on demonstrating that the Radii Diagnostic Electrophysiology Catheter (and its associated cables) is substantially equivalent to existing legally marketed predicate devices. This is achieved by showing that it has the same intended use, similar technological characteristics, and that its performance (through electrical, mechanical, and biocompatibility bench testing) "met the specifications." The document confirms that the FDA reviewed this data and found the device substantially equivalent. The information provided is consistent with the requirements for a Class II medical device seeking 510(k) clearance, which primarily involves demonstrating safety and effectiveness through substantial equivalence, often relying heavily on non-clinical performance data (bench testing) rather than extensive clinical efficacy trials typically seen for novel, higher-risk devices or software.
Ask a specific question about this device
(236 days)
CARDIAC PATHWAYS CORP.
The Arrhythmia Mapping System is intended to be used to record, view, and analyze intracardiac electrogram (EGM) and surface electrocardiograph (EKG) signals. By performing these functions, the Mapping System assists in the collection and presentation of signal information necessary for the diagnosis and localization of cardiac arrhythmias. The system is intended to be used by a Cardiologist (subspecialty Cardiac Electrophysiology) during electrophysiology studies.
Not Found
This is a 510(k) clearance letter for a device called "Arrhythmia Mapping System (8100/8300)" from 1997. It declares the device to be substantially equivalent to a predicate device.
Crucially, 510(k) clearance letters typically do not contain detailed acceptance criteria, study methodologies, or performance statistics like those requested in your prompt. Their primary purpose is to confirm substantial equivalence to a legally marketed predicate device, often based on comparisons of technological characteristics, intended use, and sometimes non-clinical (e.g., bench) testing, rather than complex clinical performance studies with acceptance criteria and defined statistical metrics.
Therefore, I cannot extract the requested information from the provided text. The document states the intended use of the device but provides no data on its performance, studies conducted, or the criteria for its acceptance.
Ask a specific question about this device
Page 1 of 1